Accelerating Parkinson's Disease drug development with federated learning approaches.

Autor: Khanna A; Neuroscience Development, Novartis AG, Basel, Switzerland., Adams J; Department of Neurology and Center for Health and Technology, University of Rochester, Rochester, NY, USA., Antoniades C; NeuroMetrology Lab, University of Oxford, Oxford, UK., Bloem BR; Radboud University Medical Centre, Nijmegen, The Netherlands., Carroll C; Translational and Clinical Research Institute, Newcastle University, Newcastle-upon-Tyne, UK., Cedarbaum J; Department of Neurology, Yale School of Medicine, New Haven, CT, 06511, USA., Cosman J; AbbVie Pharmaceuticals, North Chicago, IL, USA., Dexter DT; Parkinson's UK, 50 Broadway, London, UK., Dockendorf MF; Merck & Co., Inc., Rahway, NJ, USA., Edgerton J; Biogen Inc, Cambridge, MA, USA., Gaetano L; Neuroscience Development, Novartis AG, Basel, Switzerland., Goikoetxea E; UCB Pharmaceuticals, Leuven, Belgium., Hill D; Panoramic Digital Health, Grenoble, France., Horak F; Oregon Health and Science University, Portland, USA., Izmailova ES; Koneksa Health, One World Trade Center, 285 Fulton St., New York, NY, USA., Kangarloo T; Takeda Pharmaceuticals, Cambridge, MA, USA., Katabi D; Department of Electrical Engineering and Computer Science, Massachusetts Institute of Technology, Cambridge, MA, USA., Kopil C; The Michael J. Fox Foundation for Parkinson's Research, New York, NY, USA., Lindemann M; F. Hoffmann-La Roche Ltd, Basel, Switzerland., Mammen J; University of Massachusetts, Dartmouth, College of Nursing and Health Sciences, Dartmouth, USA., Marek K; Institute for Neurodegenerative Disorders, New Haven, CT, USA., McFarthing K; Parkinson's research advocate, Oxford, UK., Mirelman A; Faculty of Medicine and Sagol School of Neuroscience, Tel Aviv University and Tel Aviv Medical Center, Tel Aviv-Yafo, Israel., Muller M; Critical Path Institute for Parkinson's Disease Consortium, Critical Path Institute, 1840 E River Rd, Suite 100, Tucson, AZ, 85718, USA., Pagano G; F. Hoffmann-La Roche, Basel, Switzerland., Peterschmitt MJ; Research and Development, Sanofi, Cambridge, MA, USA., Ren J; Merck & Co., Inc., Rahway, NJ, USA., Rochester L; Translational and Clinical Research Institute, Newcastle University, Newcastle-upon-Tyne, UK., Sardar S; Critical Path Institute for Parkinson's Disease Consortium, Critical Path Institute, 1840 E River Rd, Suite 100, Tucson, AZ, 85718, USA., Siderowf A; University of Pennsylvania Perelman School of Medicine, Philadelphia, PA, USA., Simuni T; Feinberg School of Medicine, Northwestern University, Chicago, IL, USA., Stephenson D; Critical Path Institute for Parkinson's Disease Consortium, Critical Path Institute, 1840 E River Rd, Suite 100, Tucson, AZ, 85718, USA., Swanson-Fischer C; National Institute of Neurological Disorders and Stroke, National Institutes of Health, Bethesda, Maryland, USA., Wagner JA; Koneksa Health, One World Trade Center, 285 Fulton St., New York, NY, USA., Jones GB; Data, Design and Clinical Innovation, Novartis Pharmaceuticals, Cambridge, MA, USA. graham.jones@novartis.com.; Tufts University Medical Center, Boston, MA, USA. graham.jones@novartis.com.

Publikováno v: NPJ Parkinson's disease [NPJ Parkinsons Dis] 2024 Nov 21; Vol. 10 (1), pp. 225. Date of Electronic Publication: 2024 Nov 21.

Tento výsledek nelze pro nepřihlášené uživatele zobrazit.
K zobrazení výsledku je třeba se přihlásit.

Predicting Progression in Parkinson’s Disease Using Baseline and 1-Year Change Measures

Autor: Chahine, LM, Siderowf, A, Barnes, J, Seedorff, N, Caspell-Garcia, C, Simuni, T, Coffey, CS, Galasko, D, Mollenhauer, B, Arnedo, V, Daegele, N, Frasier, M, Tanner, C, Kieburtz, K, Marek, K, Seibyl, J, Coffey, C, Tosun-Turgut, D, Shaw, L, Trojanowski, J, Singleton, A, Toga, A, Chahine, L, Poewe, W, Foroud, T, Poston, K, Sherer, T, Chowdhury, S, Kopil, C, Casaceli, C, Dorsey, R, Wilson, R, Mahes, S, Salerno, C, Crawford, K, Casalin, P, Malferrari, G, Weisz, MG, Orr-Urtreger, A, Montine, T, Russell, D, Dahodwala, N, Giladi, N, Factor, S, Hogarth, P, Standaert, D, Hauser, R, Jankovic, J, Saint-Hilaire, M, Richard, I, Shprecher, D, Fernandez, H, Brockmann, K, Rosenthal, L, Barone, P, Espay, A, Rowe, D, Marder, K, Santiago, A, Bressman, S, Hu, S-C, Isaacson, S, Corvol, J-C, Ruiz Martinez, J, Tolosa, E, Tai, Y, Politis, M, Smejdir, D, Rees, L, Williams, K, Kausar, F, Richardson, W, Willeke, D, Peacock, S, Sommerfeld, B, Freed, A, Wakeman, K, Blair, C, Guthrie, S, Harrell, L, Hunter, C, Thomas, C-A, James, R, Zimmerman, G, Brown, V, Mule, J, Hilt, E, Ribb, K, Ainscough, S, Wethington, M, Ranola, M, Santana, HM, Moreno, J, Raymond, D, Speketer, K, Carvajal, L, Carvalho, S, Croitoru, I, Garrido, A, Payne, LM, Viswanth, V, Severt, L, Facheris, M, Soares, H, Mintun, MA, Cedarbaum, J, Taylor, P, Biglan, K, Vandenbroucke, E, Sheikh, ZH, Bingol, B, Fischer, T, Sardi, P, Forrat, R, Reith, A, Egebjerg, J, Hillert, GA, Saba, B, Min, C, Umek, R, Mather, J, De Santi, S, Post, A, Boess, F, Taylor, K, Grachev, I, Avbersek, A, Muglia, P, Merchant, K, Tauscher, J

Publikováno v: Journal of Parkinson's Disease

Author(s): Chahine, Lana M; Siderowf, Andrew; Barnes, Janel; Seedorff, Nicholas; Caspell-Garcia, Chelsea; Simuni, Tanya; Coffey, Christopher S; Galasko, Douglas; Mollenhauer, Brit; Arnedo, Vanessa; Daegele, Nichole; Frasier, Mark; Tanner, Caroline; K

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::4f1b94f69531f368cb4c876107d60d08
http://resolver.sub.uni-goettingen.de/purl?gs-1/16631

Demographic Influences on the Relationship Between Fatigue and Quality of Life in Parkinson's Disease.

Autor: Mantri S; Department of Neurology Duke University School of Medicine Durham North Carolina USA., Chahine LM; Department of Neurology University of Pittsburgh School of Medicine Pittsburgh Pennsylvania USA., Nabieva K; The Edmond J Safra Program in Parkinson's disease Toronto Western Hospital, University of Toronto Toronto Ontario Canada., Feldman R; Center for Clinical Trials and Data Coordination, Division of General Internal Medicine University of Pittsburgh School of Medicine Pittsburgh Pennsylvania USA., Althouse A; Center for Clinical Trials and Data Coordination, Division of General Internal Medicine University of Pittsburgh School of Medicine Pittsburgh Pennsylvania USA., Torsney B; Temple University College of Education and Human Development Philadelphia Pennsylvania USA., Albert SM; Behavioral and Community Health Sciences, Graduate School of Public Health University of Pittsburgh Pittsburgh Pennsylvania USA., Kopil C; The Michael J. Fox Foundation New York New York USA., Marras C; The Edmond J Safra Program in Parkinson's disease Toronto Western Hospital, University of Toronto Toronto Ontario Canada.

Publikováno v: Movement disorders clinical practice [Mov Disord Clin Pract] 2021 Oct 28; Vol. 9 (1), pp. 76-81. Date of Electronic Publication: 2021 Oct 28 (Print Publication: 2022).

Safety of Immersive Virtual Reality for the Management of Parkinson's Disease.

Autor: Pimenta Silva, Daniela^1,2,3 (AUTHOR) dsilva7@edu.ulisboa.pt, Pona-Ferreira, Filipa³ (AUTHOR), Santos, Beatriz³ (AUTHOR), Campo-Prieto, Pablo⁴ (AUTHOR) pcampo@uvigo.gal, Bouça-Machado, Raquel^2,3 (AUTHOR), Ferreira, Joaquim J.^1,2,3 (AUTHOR) jferreira@medicina.ulisboa.pt

Publikováno v: Sensors (14248220). Dec2024, Vol. 24 Issue 24, p8188. 12p.